concurrent chemoradiotherapy

You have access
Treatment Outcomes and Prognostic Factors of Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and Fluorouracil in Advanced Head and Neck Cancer
TAKAHIRO KUSAKA, KIYOTO SHIGA, KATSUNORI KATAGIRI, DAISUKE SAITO, SHIN-ICHI OIKAWA, AYA IKEDA, KODAI TSUCHIDA, JUN MIYAGUCHI, YU OHASHI, HISANORI ARIGA and KOZO TANNO

Anticancer Research December 2022, 42 (12) 6047-6056; DOI: https://doi.org/10.21873/anticanres.16116
You have access
Overall Survival of Small-cell Lung Cancer Patients With Malignant Central Airway Obstruction Who Received Chemotherapy Without Undergoing Transbronchial Interventions: A Single-institution Retrospective Study
KOSUKE KASHIWABARA, SHINJI FUJII, SHINSUKE TSUMURA and KAZUHIKO SAKAMOTO

Anticancer Research December 2022, 42 (12) 6113-6119; DOI: https://doi.org/10.21873/anticanres.16124
You have access
Sarcopenia Is an Independent Prognostic Factor for Squamous Cell Carcinoma of the Cervix Treated With Concurrent Chemoradiotherapy
SHINYU KISE, YOSHIHISA ARAKAKI, WATARU KUDAKA, TAKURO ARIGA, NAGISA KINJO, HIROSHI KOHATU and YOICHI AOKI

Anticancer Research October 2022, 42 (10) 4887-4893; DOI: https://doi.org/10.21873/anticanres.15994
You have access
Differences in the Therapeutic Effect of Chemotherapy Regimens for Concurrent Chemoradiotherapy of Locally Advanced Non-small Cell Lung Cancer
MINORU HORIUCHI, TETSUYA OGURI, YUSUKE KAGAWA, KAZUKI SONE, SATOSHI FUKUDA, TAKEHIRO UEMURA, OSAMU TAKAKUWA, KEN MAENO, KENNSUKE FUKUMITSU, YOSHIHIRO KANEMITSU, TOMOKO TAJIRI, HIROTSUGU OHKUBO, MASAYA TAKEMURA, YUTAKA ITO and AKIO NIIMI

Anticancer Research February 2022, 42 (2) 1073-1079; DOI: https://doi.org/10.21873/anticanres.15569
You have access
Prognostic Value of Hematological Parameters in Locally Advanced Cervical Cancer Patients Treated With Concurrent Chemoradiotherapy
HYUN JUNG LEE, JONG MI KIM, YOO JEONG CHIN, GUN OH CHONG, SHIN-HYUNG PARK, YOON HEE LEE, DAE GY HONG and YOON SOON LEE

Anticancer Research January 2020, 40 (1) 451-458; DOI: https://doi.org/10.21873/anticanres.13973
You have access
Lymph Node Metastases Diagnosed by ¹⁸F-FDG-PET/CT in Esophageal Squamous Cell Cancer Treated With Concurrent Chemoradiotherapy
ICHIRO OGINO, SHIGENOBU WATANABE, TOSHIHIRO MISUMI, MASAHARU HATA and CHIKARA KUNISAKI

Anticancer Research September 2019, 39 (9) 4977-4985; DOI: https://doi.org/10.21873/anticanres.13687
You have access
Sarcopenia Is Not a Prognostic Factor of Outcome in Patients With Cervical Cancer Undergoing Concurrent Chemoradiotherapy or Radiotherapy
HIROFUMI MATSUOKA, KEIICHIRO NAKAMURA, YUKO MATSUBARA, NAOYUKI IDA, TAKESHI NISHIDA, CHIKAKO OGAWA, KUNIAKI KATSI, SUSUMU KANAZAWA and HISASHI MASUYAMA

Anticancer Research February 2019, 39 (2) 933-939; DOI: https://doi.org/10.21873/anticanres.13196
You have access
Outcomes of Localized Esophageal Squamous Cell Carcinoma Patients Treated With Definitive Concurrent Chemoradiotherapy Using Either Standard or High Radiotherapy Dose: A Retrospective Study Controlling for Organ at Risk Dose
CHIA-CHIN LI, HSIN-YUAN FANG, CHEN-YUAN LIN, WEI-CHIH SHEN and CHUN-RU CHIEN

Anticancer Research January 2019, 39 (1) 511-517; DOI: https://doi.org/10.21873/anticanres.13142
You have access
Clinical Outcomes of Hypopharyngeal Cancer Receiving Definitive Radiotherapy with Concurrent Chemotherapy
MASAKUNI SAKAGUCHI, TOSHIYA MAEBAYASHI, TAKUYA AIZAWA, NAOYA ISHIBASHI and TSUTOMU SAITO

Anticancer Research February 2017, 37 (2) 941-947;
You have access
Clinical Results for Bladder Cancer Treated by Radiotherapy Without Concurrent Standard Chemotherapy
MASAKUNI SAKAGUCHI, TOSHIYA MAEBAYASHI, TAKUYA AIZAWA, NAOYA ISHIBASHI and TSUTOMU SAITO

Anticancer Research October 2016, 36 (10) 5519-5525;

Main menu

User menu

Search

concurrent chemoradiotherapy

Pages